Biotech & Medtech
Biotech & Medtech news — Tuesday 03 November 2026
19 stories from 4 sources, every one in English. Each links to its publisher.
-
The FTC Is Flexing Its Muscle in Healthcare
MedCity News
The FTC sent warning letters to 25 health plan marketers over potentially deceptive marketing practices, following its earlier letters to healthcare services companies about price transparency. The post The FTC Is Flexing Its Muscle in…
-
Flagship Merges 3 Startups to Turn Cause and Effect Insights Into Novel Medicines
MedCity News
Flagship Pioneering unveiled Etcelera, a new startup formed by combining three of the firm’s portfolio companies. Etcelera’s approach to drug R&D focuses on “causal intelligence,” which Flagship defines as predicting and understanding…
-
STAT+: Servier’s $1.55 billion muscular dystrophy drug fails first major test
STAT News
The French pharma Servier said Tuesday that an experimental drug it purchased in June for $1.55 billion in cash, plus about $1 billion more in potential milestones, failed to slow a rare form of muscular dystrophy in a long…
-
STAT+: Amid Mass General Brigham layoffs, CEO pens vague letter, stirring staff anxiety
STAT News
Less than two weeks after Mass General Brigham said it had begun laying off workers , the head of the health care system has sent employees a cryptic email saying MGB faces urgent financial challenges and needed to make improvements but…
-
Vertex, ahead of FDA decision, calms fears surrounding kidney drug
BioPharma Dive
On a conference call, executives expressed conviction in the coming launch of an IgA nephropathy medicine viewed by Wall Street investors as important to Vertex’s future.
-
STAT+: Who will get the first psychedelic approved?
STAT News
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. The midterms are here. My colleagues will be closely tracking the elections and their implications on…
-
STAT+: What do the midterms mean for health care?
STAT News
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Mind your heart health. Elections…
-
STAT+: FDA, CMS look to collaborate with states on health AI
STAT News
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Good morning health tech readers! Happy…
-
STAT+: Pharmalittle: We’re reading about a generic HIV prevention shot, Lonza buying U.S. facilities, and more
STAT News
Top of the morning to you. And a fine one it is here at the Pharmalot campus, where the official mascots are snoozing away and a breathtaking autumn landscape is visible in all directions. Moreover, a warm and shiny sun is making a welcome…
-
Healthcare’s Trust Crisis Is an Experience Crisis
MedCity News
Rebuilding trust across a fragmented healthcare landscape demands that payers and providers alike move beyond transactional relationships and prioritize transparency, empathy, and tailored communication. The post Healthcare’s Trust Crisis…
-
Looser Health IT Certification Requirements Shift Oversight to Health Systems
MedCity News
The U.S. Department of Health and Human Services (HHS) is rolling back several health IT certification requirements that could reduce certification costs for technology developers. But they may leave hospitals and health systems holding…
-
Child dies of measles in New York’s first such death in 30 years
STAT News
LOWVILLE, N.Y. — A child in rural northern New York has died after contracting measles , marking the state’s first death from the disease in 30 years, state officials announced Monday. The child died in Lewis County, about 93 miles (150…
-
Medicare Part D premiums are spiking 50% on average next year, KFF finds
BioPharma Dive
The health policy think tank urged seniors to shop carefully for prescription drug coverage during Medicare open enrollment, given skyrocketing premiums and wide variance in costs between plans.
-
UniQure gets an FDA decision date; Teva scraps brain drug study
BioPharma Dive
The FDA appears likely to hold an advisory committee for UniQure’s closely watched Huntington’s disease gene therapy. Elsewhere, a biotech’s share price was cut in half following a regulatory setback.
-
First U.S. bird flu death of the year after cattle exposure
STAT News
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . Good morning and happy election day. At the very least, after today, we can hope for a short respite from relentless…
-
‘Three-parent IVF’ was supposed to prevent mitochondrial disease. Studies are raising doubts
STAT News
The news out of the U.K. last year that eight healthy children had been born to mothers carrying disease-causing mutations in their mitochondria showed the promise of a pioneering reproductive technique known as “three-parent IVF.” The…
-
Opinion: How meditation helped me become a better doctor overnight
STAT News
Last fall I attended a meditation retreat in the Santa Cruz Mountains. I had hoped for a respite from a busy ophthalmology practice in Portland, Ore. Instead, I returned to the most difficult challenges I have faced in practice. One night…
-
Opinion: What the 2024 electoral map reveals about America’s mortality divide
STAT News
In this 2026 midterm election season, health care ranks third on voters’ minds. That’s no surprise: U.S. life expectancy persistently lags those in comparable countries despite substantially greater spending on health care. As health and…
-
Editor’s Pick: Wild Bioscience
Nature Biotechnology
Nature Biotechnology, Published online: 03 November 2026; doi:10.1038/s41587-026-03377-w Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Wild Bioscience is pursuing crop…